DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,457,101 | -8.9% | 174,510 | 0.0% | 0.39% | -36.1% |
| Q1 2023 | $2,696,179 | -55.2% | 174,510 | -52.5% | 0.61% | -57.9% |
| Q4 2022 | $6,017,081 | -47.1% | 367,119 | -40.3% | 1.45% | -36.0% |
| Q3 2022 | $11,375,000 | +3704.3% | 614,875 | +1909.4% | 2.27% | +5052.3% |
| Q4 2021 | $299,000 | -70.5% | 30,600 | +2.7% | 0.04% | -38.0% |
| Q3 2021 | $1,012,000 | -87.3% | 29,800 | -78.7% | 0.07% | -79.8% |
| Q4 2020 | $7,989,000 | -35.1% | 140,000 | -41.7% | 0.35% | -60.5% |
| Q3 2020 | $12,314,000 | +106.2% | 240,000 | +140.0% | 0.89% | +87.6% |
| Q2 2020 | $5,972,000 | -4.0% | 100,000 | 0.0% | 0.48% | -52.9% |
| Q4 2019 | $6,224,000 | – | 100,000 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |